MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.heliyon.2024.e27434

Медицинская библиотека · Heliyon · 2024

Identification of novel mutations in TPK1 and SLC19A3 genes in families exhibiting thiamine metabolism dysfunction syndrome.

Norouzi Rostami Fatemeh, Sadeghi Hossein, Hashemi-Gorji Farzad, Tehrani Fateh Sahand, Mirfakhraie Reza, Karimzadeh Parvaneh, Davarpanah Milad, Jamshidi Sanaz, Madannejad Rasoul, Moghimi Parinaz, Ekrami Mahdis, Miryounesi Mohammad, Ghasemi Mohammad-Reza

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: The occurrence of thiamine metabolism dysfunction syndrome (THMD), a rare autosomal recessive condition, may be linked to various mutations found in the TPK1 and SLC19A3 genes. The disease chiefly manifests through ataxia, muscle hypotonia, abrupt or subacute onset encephalopathy, and a decline in developmental milestones achieved during the early stages of infancy. We present findings from an investigation that involved two individuals from Iran, both of whom experienced seizures along with ataxia and hypotonia. The underlying genetic causes were found with the use of next-generation sequencing (NGS) technology, which has facilitated the detection of causal changes in a variety of genetic disorders.

MATERIAL AND

METHODS

The selection of cases for this study was based on the phenotypic and genetic information that was obtainable from the Center for Comprehensive Genetic Services. The genetic basis for the problems observed among the participants was determined through the application of whole-exome sequencing (WES). Subsequently, sanger sequencing was employed as a means of validating any identified variations suspected to be causative.

RESULTS

The first patient exhibited a homozygous mutation in the TPK1 gene, NM_022445.4:c.224 T > A:p.I75 N, resulting in the substitution of isoleucine for asparagine at position 75 (p.I75 N). In our investigation, patient 2 exhibited a homozygous variant, NM_025243.4:c.1385dupA:pY462X, within the SLC19A3 gene.

CONCLUSIONS

Collectively, when presented with patients showcasing ataxia, encephalopathy, and basal ganglia necrosis, it is essential to account for thiamine deficiency in light of the potential advantages of prompt intervention. At times, it may be feasible to rectify this deficiency through the timely administration of thiamine dosages. Accordingly, based on the results of the current investigation, these variations may be useful for the diagnosis and management of patients with THMD.

Для цитирования: Norouzi Rostami Fatemeh, Sadeghi Hossein, Hashemi-Gorji Farzad, Tehrani Fateh Sahand, Mirfakhraie Reza, Karimzadeh Parvaneh, Davarpanah Milad, Jamshidi Sanaz, Madannejad Rasoul, Moghimi Parinaz, Ekrami Mahdis, Miryounesi Mohammad, Ghasemi Mohammad-Reza. Identification of novel mutations in TPK1 and SLC19A3 genes in families exhibiting thiamine metabolism dysfunction syndrome.. Heliyon. 2024. DOI: 10.1016/j.heliyon.2024.e27434.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.